Table 1. Clinical characteristics of patients at the final visit for clinical study.

	Tacrolimus group			RASi group
	Non-Tac	Tac	p-value	Non-RASi	RASi	p-value
Number	19	18		19	18
Age (years)	41.0 ± 12.6	36.8 ± 11.3	0.258	37.0 ± 12.0	41.0 ± 12.0	0.284
Gender (male)	5 (26.3%)	6 (33.3%)	0.641	5 (26.3%)	6 (33.3%)	0.641
SBP (mmHg)	120 ± 11	123 ± 9	0.480	120 ± 11	123 ± 8	0.358
DBP (mmHg)	74 ± 8	74 ± 5	0.663	74.0 ± 8.0	74.0 ± 6.0	0.988
Hypertension	7 (36.8%)	9 (50.0%)	0.419	3 (15.8%)	13 (72.2%)	0.001
Diabetes mellitus	0 (0.0%)	1 (5.6%)	0.486	0 (0.0%)	1 (5.6%)	0.486
UPCR (g/g cr)	0.998 ± 0.479	0.649 ± 0.452	0.031	0.823 ± 0.453	0.824 ± 0.453	0.940
TA-proteinuria (g/g cr)	1.408 ± 0.441	0.611 ± 0.408	0.002	0.816 ± 0.477	0.856 ± 0.484	0.753
UACR (g/g cr)	0.711 ± 0.393	0.466 ± 0.406	0.036	0.594 ± 0.384	0.591 ± 0.453	0.799
Creatinine (mg/dL)	0.99 ± 0.27	1.10 ± 0.32	0.313	0.97 ± 0.24	1.12 ± 0.34	0.245
eGFR (mLmin/1.73 m2)	83.1 ± 24.1	77.4 ± 22.9	0.538	86.3 ± 23.9	74.1 ± 21.7	0.118
Albumin (g/dL)	4.2 ± 0.3	4.3 ± 0.3	0.425	4.1 ± 0.3	4.3 ± 0.3	0.061
Protein (g/dL)	7.1 ± 0.5	7.2 ± 0.5	0.988	7.1 ± 0.5	7.2 ± 0.5	0.343
CRP (mg/dL)	0.27 ± 0.69	0.13 ± 0.26	0.098	0.09 ± 0.11	0.32 ± 0.74	0.558
Hemoglobin (g/dL)	13.3 ± 1.3	12.9 ± 1.7	0.425	12.9 ± 1.6	13.2 ± 1.4	0.425
Hematuria	17 (89.5%)	15 (83.3%)	0.660	18 (94.7%)	14 (77.8%)	0.180
RASi	8 (42.1%)	10 (55.6%)	0.413	(-)	(-)	(-)
Tacrolimus	(-)	(-)	(-)	8 (42.1%)	10 (55.6%)	0.413

Values expressed as either mean ± standard deviation, or number (percentage).